Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $90.0882 (0.5%) ($88.8691 - $90.2721) on Mon. Jul. 2, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.75% (three month average) | RSI | 29 | Latest Price | $90.0882(0.5%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -3.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(50%) IVE(49%) IWD(48%) SPLV(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.875% in a week (0% probabilities). VIXM(-14%) TLT(-14%) VXX(-13%) UUP(-11%) DIA(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.875% (StdDev 1.75%) | Hourly BBV | 0 () | Intraday Trend | 1.1% | | | |
|
1 - 5 Day Possible Target | $84.49(-6.21%) | Resistance Level | $93.3 | 5 Day Moving Average | $89.37(0.8%) | 10 Day Moving Average | $90.85(-0.84%) | 20 Day Moving Average | $93.3(-3.44%) | To recent high | -12.4% | To recent low | 4.8% | Market Cap | $158.941b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |